Slide 1: Thyrocare - Tests you can trust
0 Thyrocare Tests you can trust January 23, 2025 I To, National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeeboy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400 051 Mumbai- 400 001 (SYMBOL: THYROCARE) (SCRIP CODE 539871) Sub: Presentation on Un‐audited
Slide 2: Thyrocare Earnings Presentation Q3 FY25
Thyrocare Earnings Presentation Q3 FY25
Slide 3: Safe harbour statement
~ Thyrocare· Safe harbour statement Tests you can trust Statements in this presentation describing the Company’s performance may be “forward looking statements” within the meaning of applicable security laws and regulations. Actual results may differ materially from those directly or indirectly expr
Slide 4: Agenda
~ Thyrocare· Agenda Tests you can trust Latest updates 01 Latest updates Performance highlights 02 Performance highlights Financial performance 03 Financial performance Going forward strategy 04 Going forward strategy 02
Slide 5: Delivered 23% YoY revenue growth in Q3 FY25 while maintaining highest quality standards
Delivered 23% YoY revenue growth in Q3 FY25 while maintaining ~ Thyrocare· highest quality standards Tests you can trust India’s first and only 100% NABL accredited national diagnostic laboratory chain ~ Thyrocare· Tests you can trust I I i i i i i i _______! i !...--· Financial Parameters Operation
Slide 6: Our USPs
~ Thyrocare· Our USPs Tests you can trust First National Reports Diagnostic Chain released within to have 100% average TAT of of its Labs with NABL tor ••• 3.65 Accreditation# I llt•IIJiJ-._, ~ of sample Reports verified by expert trust that Thyrocare reports are •®i •) =Iii h·1t·i•i~ift -.i i reach
Slide 7: Nationwide network dedicated to serving the masses
~ Thyrocare· Nationwide network dedicated to serving the masses Tests you can trust 38 Thyrocare NABL network labs (29) 29 29 29 17 12 Q3FY23 - Q3FY24 No of labs NABL labs Thyrocare Labs (29) : All NABL accredited Q3FY25 ► West : Navi Mumbai, Mumbai (Kurla), Pune, Raipur, Ahmedabad, Nagpur, Mumbai (
Slide 8: India's first and only 100% NABL accredited national diagnostic laboratory chain
India’s first and only 100% NABL accredited national diagnostic ~ Thyrocare· laboratory chain Tests you can trust This remarkable achievement is a testament to the highest standards and stringent benchmarks for quality, accuracy and safety Felicitation by NABL for 100% NABL accreditation Our journey
Slide 9: Strategic initiatives for footprint expansion
~ Thyrocare· Strategic initiatives for footprint expansion Tests you can trust Polo · Clinical Right Treatment Begins \tilth Right Diagnosis Diagnostics ► Thyrocare completed the acquisition of Polo Labs on July 29, ► On October 11, 2024, Thyrocare completed the acquisition of the 2024. clinical dia
Slide 10: Agenda
~ Thyrocare· Agenda Tests you can trust Latest updates 01 Latest updates Performance highlights 02 Performance highlights Financial performance 03 Financial performance Going forward strategy 04 Going forward strategy 08
Slide 11: Quarter health check - Financial Performance Q3 FY25
~ Thyrocare· Quarter health check - Financial Performance Q3 FY25 Tests you can trust YoY TTL Consolidated YoY Pathology Revenue +23% Revenue* +24% YoY Radiology YoY Normalized Revenue** +13% EBITDA # +42% YoY Reported # EBITDA +32% Normalized EBITDA% 30% * Pathology business excluding materials & o
Slide 12: Year to date health check - Financial Performance YTD FY25
~ Thyrocare· Year to date health check - Financial Performance YTD FY25 Tests you can trust YoY TTL Consolidated YoY Pathology Revenue +20% Revenue* +20% YoY Radiology YoY Normalized Revenue** +16% EBITDA # +24% YoY Reported # EBITDA +27% Normalized EBITDA% 29% * Pathology business excluding materia
Slide 13: Strong and consistent growth outlined by key metrics
~ Thyrocare· Strong and consistent growth outlined by key metrics Tests you can trust Tests performed (Mn) Patients (Mn) Active franchisees (#) +14% +13% ... -·- +26% t . t 39.0 9,158 3.9 7,171 7,284 3.7 33.9 34.2 3.5 Q3FY23 Q3FY24 Q3FY25 Q3FY23 Q3FY24 Q3FY25 Q3FY23 Q3FY24 Q3FY25 Revenue per test (I
Slide 14: 23% YoY revenue growth in overall business; 42% YoY growth in Normalized EBITDA
23% YoY revenue growth in overall business ; 42% YoY growth in ~ Thyrocare· Normalized EBITDA Tests you can trust Consolidated Revenue (INR Cr) Normalized EBITDA (INR Cr) +23% -.-.-.-.-.-.-.-.-.-.-.-.-.-.-.-.-.-.-.-...' +42% ... -.-.-.-.-.-.-.-.-.-.-.-.-.... -.-.-.-.' ... ... • .. 177.4 165.9 50.7 .
Slide 15: Franchise revenue grew by 24% YoY; Partnerships grew by 23% YoY
Franchise revenue grew by 24% YoY ; Partnerships grew by 23% ~ Thyrocare· YoY Tests you can trust Pathology Revenue (Rs Cr) YoY% Pathology Workload (Lakhs) YoY% 46.2 ----------·-----. [_) 43.6 98.6 41.4 ------------·-------.. 40.1 88.5 94.2 [ +24% ) ------- · +13% .. 36.6 76.0 _______...--____...- 8
Slide 16: Strong organic growth with a potential to expand further with M&A
~ Thyrocare· Strong organic growth with a potential to expand further with M&A Tests you can trust Consolidated Revenue Particulars (INR Cr) Q3FY25 Organic revenue (A) 160.9 Inorganic revenue (B) 5.0 Consolidated revenue (A+B) 165.9 Comparison of organic and consolidated revenue of Q3FY25 with Q3FY2
Slide 17: Agenda
~ Thyrocare· Agenda Tests you can trust Latest updates 01 Latest updates Performance highlights 02 Performance highlights Financial performance 03 Financial performance Going forward strategy 04 Going forward strategy 15
Slide 18: Income statement - TTL Standalone
~ Thyrocare· Income statement - TTL Standalone : Increase in PAT by 29% YoY Tests you can trust , ,------------------------------------------~ ' \ Quarter Year To Date I Pathology revenue grew by 24% YoY, INR crore Q3FY25 Q3FY24 YoY YTDFY25 YTDFY24 YoY Franchise grew by 24%; Partnerships Revenue fro
Slide 19: Income statement - NHL Standalone
~ Thyrocare· Income statement - NHL Standalone : Increase in revenue by 14% YoY Tests you can trust ,' -------------------------------------------,\ Quarter Year To Date I NHL Revenue grew 14% YoY on INR crore Q3FY25 Q3FY24 YoY YTDFY25 YTDFY24 YoY account of increase in FDG sales and Revenue from op
Slide 20: Income statement - TTL Consolidated
~ Thyrocare· Income statement - TTL Consolidated : Increase in PAT by 30% YoY Tests you can trust ,' '\ Quarter Year To Date I Revenue from operations include INR crore Q3FY25 Q3FY24 YoY YTDFY25 YTDFY24 YoY Pulse Hitech, Think Health and Polo Revenue from operations 165.9 134.7 23% 500.2 417.6 20% L
Slide 21: Agenda
~ Thyrocare· Agenda Tests you can trust Latest updates 01 Latest updates Performance highlights 02 Performance highlights Financial performance 03 Financial performance Going forward strategy 04 Going forward strategy 19
Slide 22: Vision & Mission
~ Thyrocare· Vision & Mission Tests you can trust d Global in our reach, excellence in our experience @ To ensure everyone has access to quality & affordable diagnostics M 1",ss,1on " 20
Slide 23: Going forward - Key pillars of growth
~ Thyrocare· Going forward - Key pillars of growth Tests you can trust PUBLIC & PRIVATE PARTNERSHIPS ► Going deeper into ► Expanding our Strengthening our India with focused partnerships towards presence in Tanzania test menu insurance and ECG at to deliver accessible, ► Strengthening our home high-
Slide 24: Our strategy remains to be a B2B service provider with an affordable value driven model
Our strategy remains to be a B2B service provider with an affordable ~ Thyrocare· value driven model based on scale efficiencies Tests you can trust ~ Thyrocare· Tests you can trust I I i i i i i i i i i i i i i i r·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·-·
Slide 25: Thank You
0 Thyrocare Tests you can trust For Any queries, please reach out to investor_relations@thyrocare.com Thank You Disclaimer This presentation is for information purposes only and it contains general background information about the Company's activities. The Company assumes no responsibility to public